Guidance

National protocol for COVID-19 mRNA vaccine (5 to 17 years ofand age)over)

Protocol for the administration of COVID-19 mRNA vaccine to individuals aged 5 toyears 17and years over in accordance with the national COVID-19 vaccination programme.

From:
UK Health Security Agency
Published
3 April 2023
Last updated
218 AprilSeptember 2024 — See all updates

Applies to England

Documents

National protocol for COVID-19 mRNA vaccine (5 to 17 years ofand age)over)

Ref: UKHSA gateway number GOV-16168GOV-17084

MS Word Document, 169157 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This protocol is for the administration of COVID-19 mRNA vaccine to childreneligible andindividuals young people aged 5 toyears 17and yearsover in accordance with the national COVID-19 vaccination programme by appropriately trained persons.

National protocol for COVID-19 mRNA vaccine (5 to 17 years ofand age)over) version 4.001.00 is valid from 8 April3 October 2024 to 3031 JuneMarch 2024.2025.

The corresponding COVID-19 PGD for use in individuals aged 5 toyears 17and yearsover will be available at NHS England.

Updates to this page

Published 3 April 2023
Last updated 218 AprilSeptember 2024 + show all updates

  1. Added National protocol for COVID-19 mRNA vaccine (5 years and over) version 1.00.

  2. Added version 4 – see page 3 for change history.

  3. Added version 3 – see page 3 for change history.

  4. Added version 02.00 – see page 3 for change history.

  5. First published.

Sign up for emails or print this page